Repligen Corporation Equity-NMS: RGEN

Healthcare

Medical Instruments & Supplies

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$155.99
Open :	$156.54
Today's high :	$158.07
Today's low :	$151.5
52W low :	$113.5
52W high :	$211.13
1Y :	-14.89%
5Y :	74.11%
EPS(TTM): :	-0.03
Shares O/S :	56.03 M
Market cap :	8.76 B

What is the share price of Repligen Corporation today?

Repligen Corporation (RGEN) share price as of December 14, 2024, is $156.41. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Repligen Corporation?

Yes, Indian Investors can invest in the Repligen Corporation (RGEN) Share by opening an international trading account with Angel One.

How can I purchase Repligen Corporation shares in India?

Purchasing Repligen Corporation (RGEN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Repligen Corporation (RGEN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Repligen Corporation?

Yes, you can purchase fractional shares of Repligen Corporation (RGEN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Repligen Corporation?

The market capitalization of Repligen Corporation on December 14, 2024, is $8.76 B.

In which sector Repligen Corporation belongs?

Repligen Corporation operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.

What documents are required to invest in Repligen Corporation stocks?

In order to invest in Repligen Corporation (RGEN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.